Loading…

A - 48 Neuropsychiatric Symptom Severity Predicts Rate of Executive Function Decline

Abstract Objective Neuropsychiatric symptoms (NPS) are considered diagnostic and prognostic indicators of dementia and are attributable to neurodegenerative processes. NPS are distressing for patients and caregivers and are associated with accelerated functional decline, hospitalization, and institu...

Full description

Saved in:
Bibliographic Details
Published in:Archives of clinical neuropsychology 2023-10, Vol.38 (7), p.1211-1211
Main Authors: Goodwin, Grace J, Singsank, Katie T, Maloy-Robertson, Myjae, Tanner, Denise, Salva, Christine, Briley, D A, John, Samantha E
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Abstract Objective Neuropsychiatric symptoms (NPS) are considered diagnostic and prognostic indicators of dementia and are attributable to neurodegenerative processes. NPS are distressing for patients and caregivers and are associated with accelerated functional decline, hospitalization, and institutionalization. Evaluation of NPS effects on disease course may reduce patient and caregiver distress and support development of personalized treatments. We examined whether baseline NPS predicted the rate of executive function (EF) decline among older adults with cognitive impairment. Method Older adults (n = 1155) with cognitive impairment and four years of data were selected from the National Alzheimer’s Coordinating Center database v3-v3.2. Overall EF was estimated with a latent factor indicated by scores on Number Span Backward, Letter Fluency, and Trail Making-Part B. Strict temporal invariance was established. A curve of factors (CUFF) latent growth curve model was estimated to examine rate of change. Baseline NPS severity was entered as a predictor to examine its influence on the rate of change in EF over time. Results The predicted CUFF model exhibited good fit (χ2[69] = 201.46, p 
ISSN:1873-5843
1873-5843
DOI:10.1093/arclin/acad067.065